Compounds > fluorodopa f 18
Page last updated: 2024-08-24

fluorodopa f 18 and Glial Cell Tumors

fluorodopa f 18 has been researched along with Glial Cell Tumors in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (2.50)18.2507
2000's5 (12.50)29.6817
2010's28 (70.00)24.3611
2020's6 (15.00)2.80

Authors

AuthorsStudies
Breen, WG; Brinkmann, DH; Brown, PD; Giri, S; Hunt, CH; Jacobson, SB; Jones, JE; Kizilbash, SH; Laack, NN; Mahajan, A; Pafundi, DH; Routman, DM; Ruff, MW; Uhm, JH; Youland, RS1
Higgins, GS; McGowan, DR; Plaha, P; Roach, JR1
Bund, C; Cebula, H; Chibbaro, S; Lefebvre, F; Lhermitte, B; Namer, IJ; Pin, Y; Proust, F; Todeschi, J1
Bertaux, M; Bielle, F; Choquet, S; Garcilazo, Y; Kas, A; Mokhtari, K; Ollivier, M; Rozenblum, L1
Albert, NL; Castello, A; Galldiks, N; Girard, A; Guedj, E; Lopci, E; Verger, A; Zaragori, T1
Cloughesy, TF; Ellingson, BM; Hagiwara, A; Lai, A; Liau, LM; Nghiemphu, PL; Oughourlian, TC; Raymond, C; Salamon, N; Tatekawa, H; Wang, C; Yao, J1
Capelle, L; Itti, E; Kauv, P; Louarn, N; Mokhtari, K1
Carideo, L; Cicone, F; Mamede, M; Minniti, G; Russo, I; Scaringi, C; Scopinaro, F1
Brinkmann, DH; Giannini, C; Hunt, CH; Kemp, BJ; Laack, NN; Lowe, VJ; Morris, JM; Pafundi, DH; Parney, IF; Youland, RS1
Arcella, A; Carideo, L; Cicone, F; Giangaspero, F; Minniti, G; Scaringi, C; Scopinaro, F1
Bellu, L; Bertin, D; Caccese, M; Cuppari, L; Evangelista, L; Lombardi, G; Reccia, P; Zagonel, V1
Carideo, L; Cicone, F; Minniti, G; Scopinaro, F1
Brinkmann, DH; Giannini, C; Grams, MP; Hoover, JM; Hu, LS; Kemp, BJ; Laack, NN; Lowe, VJ; Morris, JM; Pafundi, DH; Parney, IF; Sarkaria, JN; Youland, RS1
Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P1
Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Kumar, A; Malhotra, A; Sharma, P; Singla, S1
Bal, C; Bandopadhyaya, GP; Goenka, A; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P1
Benard, F; Chan, EK; Cheung, A; Hsu, F; Kosztyla, R; Ma, R; Moiseenko, V; Nichol, A; Wilson, D; Zhang, S1
Bal, C; Ballal, S; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Sharma, P1
Cloughesy, TF; Dahlbom, M; Huang, SC; Phelps, ME; Schiepers, C; Wardak, M1
Chen, W; Cloughesy, TF; Czernin, J; Elashoff, D; Ellingson, BM; Geist, C; Grogan, T; Phelps, ME; Pope, WB; Schwarzenberg, J; Silverman, DH1
Bluemel, C; Buck, AK; Czernin, J; Ernestus, RI; Herrmann, K; Homola, GA; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Monoranu, CM; Samnick, S1
Chen, W; Cloughesy, TF; Czernin, J; Ellingson, BM; Harris, RJ; Karavaeva, E; Lai, A; Leu, K; Liau, LM; Nghiemphu, PL; Pope, WB; Shabihkhani, M; Yong, WH1
Bozzao, A; Cicone, F; Filss, CP; Galldiks, N; Langen, KJ; Minniti, G; Papa, A; Rossi-Espagnet, C; Scaringi, C; Scopinaro, F; Shah, NJ1
Garrè, ML; Morana, G; Nobili, F; Piccardo, A; Rossi, A1
Bell, C; Dowson, N; Fay, M; Gal, Y; Puttick, S; Rose, S; Smith, J; Thomas, P1
Blonski, M; Janvier, L; Karcher, G; Morel, O; Olivier, P; Taillandier, L; Verger, A; Vignaud, JM1
Garrè, ML; Lopci, E; Massollo, M; Morana, G; Naseri, M; Piccardo, A; Puntoni, M; Rossi, A; Severino, M; Tortora, D1
Bozzao, A; Cicone, F; Mancuso, V; Minniti, G; Napolitano, A; Romano, A; Rossi Espagnet, MC; Scaringi, C1
Bund, C; Chenard, MP; Heimburger, C; Imperiale, A; Kremer, S; Lefebvre, F; Lhermitte, B; Namer, IJ; Proust, F1
Bialecki, E; Chinot, O; Colin, C; Figarella-Branger, D; Guedj, E; Metellus, P; Sala, Q; Taieb, D; Verger, A1
Chen, W; Cloughesy, T; Czernin, J; Freitas, B; Ledezma, CJ; Pope, W; Sai, V1
D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R1
Calabria, F; Schillaci, O1
Brinkmann, DH; Giannini, C; Kitange, GJ; Laack, NN; Lowe, VJ; Pafundi, DH; Parney, IF; Peterson, TE; Pokorny, JL; Ramiscal, JA; Sarkaria, JN; Youland, RS1
De Sanctis, V; Di Stefano, D; Enrici, RM; Esposito, V; Falco, T; Lanzetta, G; Minniti, G; Scaringi, C1
Buvat, I; Capelle, L; Dulou, R; Dutertre, G; Foehrenbach, H; Gontier, E; Guillevin, R; Lahutte, M; Nioche, C; Soret, M1
Ametamey, SM; Belokon, YN; Fedorova, OS; Krasikova, RN; Kuznetsova, OF; Mosevich, IK; Nader, M; Schubiger, PA; Shatik, SV; Vyskocil, S; Zaitsev, VV1
Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E1
Chen, W; Seibyl, JP; Silverman, DH1
Heiss, WD; Herholz, K; Lanfermann, H; Pietrzyk, U; Thiel, A; Wagner, R; Wienhard, K1

Reviews

5 review(s) available for fluorodopa f 18 and Glial Cell Tumors

ArticleYear
The role of [
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Adult; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Grading; Positron-Emission Tomography; Quality of Life

2022
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
    Current radiopharmaceuticals, 2019, Volume: 12, Issue:3

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tyrosine

2019
Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma.
    Nuclear medicine and biology, 2015, Volume: 42, Issue:10

    Topics: Dihydroxyphenylalanine; Feasibility Studies; Glioma; Humans; Neoplasm Grading; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted

2015
[PET and malignant cerebral tumors].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:9 Pt 2

    Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals

2006
3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors.
    Seminars in nuclear medicine, 2007, Volume: 37, Issue:6

    Topics: Adrenal Gland Neoplasms; Amino Acids; Brain Neoplasms; Caudate Nucleus; Dihydroxyphenylalanine; Fluorine Radioisotopes; Glioma; Humans; Movement Disorders; Neuroendocrine Tumors; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Radiopharmaceuticals

2007

Trials

4 trial(s) available for fluorodopa f 18 and Glial Cell Tumors

ArticleYear
Initial results of a phase II trial of
    Journal of neuro-oncology, 2022, Volume: 158, Issue:3

    Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Re-Irradiation

2022
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
    Journal of neuro-oncology, 2018, Volume: 137, Issue:3

    Topics: Adolescent; Adult; Brain; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Young Adult

2018
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:7

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult

2013
Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:2

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Multimodal Imaging; Organotechnetium Compounds; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Recurrence; Sugar Acids; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2014

Other Studies

31 other study(ies) available for fluorodopa f 18 and Glial Cell Tumors

ArticleYear
Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection.
    Neuro-Chirurgie, 2019, Volume: 65, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain Neoplasms; Child; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Robotics; Sensitivity and Specificity; Stereotaxic Techniques; Young Adult

2019
18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral Amyloidoma.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:4

    Topics: Aged; Amyloidosis; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Glioma; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2020
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.
    Clinical nuclear medicine, 2021, Volume: 46, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Progression-Free Survival

2021
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:12

    Topics: Adult; Biological Transport; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Positron-Emission Tomography; Retrospective Studies; ROC Curve

2020
Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas.
    Clinical nuclear medicine, 2021, Jul-01, Volume: 46, Issue:7

    Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography

2021
    The British journal of radiology, 2018, Volume: 91, Issue:1084

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Temozolomide; Tumor Burden

2018
    Annals of nuclear medicine, 2019, Volume: 33, Issue:4

    Topics: Biological Transport; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Survival Analysis

2019
The mean striatal
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:5

    Topics: Amino Acids; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Tumor Burden

2019
Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
    Neuro-oncology, 2013, Volume: 15, Issue:8

    Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Follow-Up Studies; Glioma; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Grading; Neurosurgical Procedures; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Surgery, Computer-Assisted; Tissue Distribution; Young Adult

2013
Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.
    European radiology, 2013, Volume: 23, Issue:9

    Topics: Adult; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome

2013
High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    International journal of radiation oncology, biology, physics, 2013, Dec-01, Volume: 87, Issue:5

    Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tumor Burden; Young Adult

2013
Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
    European journal of radiology, 2014, Volume: 83, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Glioma; Humans; India; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Young Adult

2014
¹⁸F-FLT    and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:6

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Data Interpretation, Statistical; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Glioma; Humans; Irinotecan; Kinetics; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tissue Distribution

2014
Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jul-01, Volume: 20, Issue:13

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Treatment Outcome; Tumor Burden

2014
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Basal Ganglia; Biopsy; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Recurrence; Tyrosine

2014
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
    Molecular imaging and biology, 2015, Volume: 17, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Contrast Media; Diffusion; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Mitosis; Mitotic Index; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Young Adult

2015
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.
    European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:6

    Topics: Adult; Aged; Brain Neoplasms; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals

2015
Late Persistent Increased Putaminal 18F-DOPA Uptake Following Ipsilateral Frontal Resection: Evidence for Corticostriatal Synaptic Plasticity?
    Clinical nuclear medicine, 2015, Volume: 40, Issue:9

    Topics: Adolescent; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Male; Neuronal Plasticity; Putamen; Radionuclide Imaging; Radiopharmaceuticals

2015
Correlation of SUV-Derived Indices With Tumoral Aggressiveness of Gliomas in Static 18F-FDOPA PET: Use in Clinical Practice.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals

2015
Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; False Negative Reactions; False Positive Reactions; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neostriatum; Positron Emission Tomography Computed Tomography; Retrospective Studies

2016
Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    The British journal of radiology, 2016, Volume: 89, Issue:1066

    Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dihydroxyphenylalanine; Female; Follow-Up Studies; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity

2016
FDOPA PET-CT of Nonenhancing Brain Tumors.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:4

    Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals

2017
IDH mutation is paradoxically associated with higher
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:8

    Topics: Adult; Biological Transport; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies

2017
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    European journal of radiology, 2009, Volume: 71, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique

2009
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:12

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult

2009
Recurrent glioma and crossed cerebellar diaschisis in a patient examined with 18F-DOPA and 18F-FDG PET/CT.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:9

    Topics: Cerebellar Diseases; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Middle Aged; Radionuclide Imaging; Recurrence

2012
The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.
    Journal of neuro-oncology, 2013, Volume: 111, Issue:1

    Topics: Animals; Biological Transport; Blotting, Western; Brain Neoplasms; Dihydroxyphenylalanine; Fluorescent Antibody Technique; Fluorine Radioisotopes; Glioma; Humans; Immunoenzyme Techniques; Large Neutral Amino Acid-Transporter 1; Mice; Neoplasm Grading; Positron-Emission Tomography; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured

2013
Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
    Journal of neuro-oncology, 2013, Volume: 111, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine; Disease-Free Survival; Female; Follow-Up Studies; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Radiosurgery; Retrospective Studies; Temozolomide

2013
Evaluation of quantitative criteria for glioma grading with static and dynamic 18F-FDopa PET/CT.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Young Adult

2013
Catalytic enantioselective synthesis of 18F-fluorinated alpha-amino acids under phase-transfer conditions using (S)-NOBIN.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:5

    Topics: 2-Naphthylamine; Animals; Catalysis; Dihydroxyphenylalanine; Fluorine Radioisotopes; Glioma; Isomerism; Isotope Labeling; Metabolic Clearance Rate; Naphthols; Organ Specificity; Phase Transition; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution; Tyrosine

2004
F-Dopa as an amino acid tracer to detect brain tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:7

    Topics: Brain; Brain Neoplasms; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Magnetic Resonance Imaging; Methionine; Middle Aged; Oxygen Radioisotopes; Tomography, Emission-Computed; Water

1996